Should pharmacies be looking for a 'fee for service, not free for service' business model? And how long can independent community pharmacies continue to compete against the multiples?
Healthcare Global takes a look at what some of the wealthiest business men in the world have done to support medical research
Asia provides US and European firms with huge opportunities for growth in the pharmaceuticals sector
Pharmaceutical manufacturers are having to change the way they do business in order to survive the current financial restraints
An organ transaction occurs every hour on the black market, according to the World Health Organisation
Auranofin, which is sold under the trade name of ridaura, is reportedly 10 times more effective than the existing treatment for amoebic infections
We look at what companies in the healthcare industry can do attract and retain skilled employees in such a competitive market
The UK's poor record on vocational rehab represents an opportunity for the private healthcare sector
Oxfam is warning the World Health Organisation is suffering from a severe financial crisis at a time when demands on the organisation are increasing
The pharmaceutical company already owns almost 20 percent of the chemical proteomics firm
